Cargando…
Ethoxy acetalated dextran-based nanocarriers accomplish efficient inhibition of leukotriene formation by a novel FLAP antagonist in human leukocytes and blood
Leukotrienes are pro-inflammatory lipid mediators generated by 5-lipoxygenase aided by the 5-lipoxygenase-activating protein (FLAP). BRP-201, a novel benzimidazole-based FLAP antagonist, inhibits leukotriene biosynthesis in isolated leukocytes. However, like other FLAP antagonists, BRP-201 fails to...
Autores principales: | Kretzer, Christian, Shkodra, Blerina, Klemm, Paul, Jordan, Paul M., Schröder, Daniel, Cinar, Gizem, Vollrath, Antje, Schubert, Stephanie, Nischang, Ivo, Hoeppener, Stephanie, Stumpf, Steffi, Banoglu, Erden, Gladigau, Frederike, Bilancia, Rossella, Rossi, Antonietta, Eggeling, Christian, Neugebauer, Ute, Schubert, Ulrich S., Werz, Oliver |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8966466/ https://www.ncbi.nlm.nih.gov/pubmed/34971430 http://dx.doi.org/10.1007/s00018-021-04039-7 |
Ejemplares similares
-
Ethoxy acetalated dextran nanoparticles for drug delivery: A comparative study of formulation methods
por: Behnke, Mira, et al.
Publicado: (2023) -
Encapsulation of the dual FLAP/mPEGS-1 inhibitor BRP-187 into acetalated dextran and PLGA nanoparticles improves its cellular bioactivity
por: Shkodra-Pula, Blerina, et al.
Publicado: (2020) -
Shifting the Biosynthesis of Leukotrienes Toward Specialized Pro-Resolving Mediators by the 5-Lipoxygenase-Activating Protein (FLAP) Antagonist BRP-201
por: Kretzer, Christian, et al.
Publicado: (2022) -
Effect of Crystallinity on the Properties of Polycaprolactone Nanoparticles Containing the Dual FLAP/mPEGS-1 Inhibitor BRP-187
por: Vollrath, Antje, et al.
Publicado: (2021) -
Formulation of Liver-Specific PLGA-DY-635 Nanoparticles Loaded with the Protein Kinase C Inhibitor Bisindolylmaleimide I
por: Shkodra, Blerina, et al.
Publicado: (2020)